Priming Human Repopulating Hematopoietic Stem and Progenitor Cells for Cas9/sgRNA Gene Targeting

Carsten T. Charlesworth(Stanford University), Joab Camarena(Stanford University), M. Kyle Cromer(Stanford University), Sriram Vaidyanathan(Stanford University), Rasmus O. Bak(Stanford University), Jason Carte(Thermo Fisher Scientific (United States)), Jason Potter(Thermo Fisher Scientific (United States)), Daniel P. Dever(Stanford Medicine), Matthew H. Porteus(Stanford University)
Molecular Therapy — Nucleic Acids
May 3, 2018
Cited by 112Open Access
Full Text

Abstract

cells/mL) prior to HBB targeting, HSPC expansion rates are significantly positively correlated with HR frequencies in vitro as well as in repopulating cells in immunodeficient NSG mice in vivo. We also show that culturing fluorescence-activated cell sorting (FACS)-enriched HBB-targeted HSPCs at low cell densities in the presence of the small molecules, UM171 and SR1, stimulates the expansion of gene-edited HSPCs as measured by higher engraftment levels in immunodeficient mice. This work serves not only as an optimized protocol for genome editing HSPCs at the HBB locus for the treatment of β-hemoglobinopathies but also as a foundation for editing HSPCs at other loci for both basic and translational research.


Related Papers

No related papers found

Powered by citation graph analysis